{
    "output": [
        [
            "Nuvectra Corporation",
            "COMP",
            "Announce",
            "Preliminary Unaudited Revenue",
            "ECON_INDICATOR"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Operate_In",
            "Neurostimulation Medical Device Industry",
            "SECTOR"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Has",
            "Algovita Spinal Cord Stimulation System",
            "PRODUCT"
        ],
        [
            "Algovita Spinal Cord Stimulation System",
            "PRODUCT",
            "Operate_In",
            "Chronic Intractable Pain Treatment",
            "SECTOR"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Under_Development",
            "Sacral Neuromodulation",
            "PRODUCT"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Under_Development",
            "Deep Brain Stimulation",
            "PRODUCT"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Has_Subsidiary",
            "NeuroNexus",
            "ORG"
        ],
        [
            "NeuroNexus",
            "ORG",
            "Designs_Manufactures_Markets",
            "Leading-Edge Neural-Interface Technologies",
            "PRODUCT"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Has_Risk",
            "Forward-Looking Statements",
            "CONCEPT"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Has_Plan",
            "Release Fourth Quarter and Full Year 2017 Financial Results",
            "EVENT"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Has_Product",
            "Virtis SNM System",
            "PRODUCT"
        ],
        [
            "Virtis SNM System",
            "PRODUCT",
            "Has_Regulatory_Approval_Uncertainty",
            "United States, Europe",
            "GPE"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Has_Development_Plan",
            "Neurostimulation Technology Platform",
            "CONCEPT"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Has_Strategy",
            "Business Development and Growth Opportunities",
            "CONCEPT"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Has_Partnership",
            "Third Parties",
            "ORG"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Has_Intellectual_Property_Rights",
            "Algovita",
            "PRODUCT"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Has_Sales_Force",
            "United States",
            "GPE"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Has_Credit_Facility",
            "null",
            "null"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Has_Milestone",
            "Trailing Six Month Revenue",
            "ECON_INDICATOR"
        ],
        [
            "Nuvectra Corporation",
            "COMP",
            "Has_Capital_Raise_Plan",
            "Public Offering, Private Equity, Debt Financings, Strategic Partnerships",
            "CONCEPT"
        ]
    ]
}